FDA Import Refusal F23-9340393-6/10002/2 — Novo Nordisk A/S - 25A-B
The FDA refused shipment F23-9340393-6/10002/2 from Novo Nordisk A/S - 25A-B (Denmark) on Sep 3, 2025. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 2 other import refusals on record.
Refusal Details
- Date
- Sep 3, 2025
- Country
- Denmark
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY72 SEMAGLUTIDE (ANTI-DIABETIC)
- Charges
- 75